Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 20 de 56
Filtrar
1.
J Neurophysiol ; 123(1): 356-366, 2020 01 01.
Artículo en Inglés | MEDLINE | ID: mdl-31747332

RESUMEN

Wide-field calcium imaging is often used to measure brain dynamics in behaving mice. With a large field of view and a high sampling rate, wide-field imaging can monitor activity from several distant cortical areas simultaneously, revealing cortical interactions. Interpretation of wide-field images is complicated, however, by the absorption of light by hemoglobin, which can substantially affect the measured fluorescence. One approach to separating hemodynamics and calcium signals is to use multiwavelength backscatter recordings to measure light absorption by hemoglobin. Following this approach, we develop a spatially detailed regression-based method to estimate hemodynamics. This Spatial Model is based on a linear form of the Beer-Lambert relationship but is fit at every pixel in the image and does not rely on the estimation of physical parameters. In awake mice of three transgenic lines, the Spatial Model offers improved separation of hemodynamics and changes in GCaMP fluorescence. The improvement is pronounced near blood vessels and, in contrast with the Beer-Lambert equations, can remove vascular artifacts along the sagittal midline and in general permits more accurate fluorescence-based determination of neuronal activity across the cortex.NEW & NOTEWORTHY This paper addresses a well-known and strong source of contamination in wide-field calcium-imaging data: hemodynamics. To guide researchers toward the best method to separate calcium signals from hemodynamics, we compare the performance of several methods in three commonly used mouse lines and present a novel regression model that outperforms the other techniques we consider.


Asunto(s)
Conducta Animal/fisiología , Proteínas de Unión al Calcio , Calcio , Corteza Cerebral/diagnóstico por imagen , Proteínas Fluorescentes Verdes , Hemodinámica/fisiología , Neuroimagen , Animales , Femenino , Fluorescencia , Masculino , Ratones , Ratones Transgénicos , Microscopía Electrónica , Modelos Teóricos , Neuroimagen/métodos , Neuroimagen/normas , Reconocimiento Visual de Modelos/fisiología
2.
Magn Reson Med ; 71(1): 326-32, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23529973

RESUMEN

PURPOSE: A novel method based on the use of Yb-HPDO3A as MRI Para-CEST agent for in vivo pH mapping of the tumor region in a melanoma murine model is reported. This method does not require the knowledge of the concentration of the imaging agent. METHODS: C57BL/6-mice were inoculated with B16-F10 cells. CEST-MR images of tumor and bladder were acquired upon the i.v. administration of Yb-HPDO3A (1.2 mmol/Kg). pH was assessed by the use of a ratiometric method. RESULTS: Yb-HPDO3A distributes well in the extracellular space of the tumor allowing the detection of good levels of saturation transfer (ST). It is excreted throughout kidneys and accumulated in the bladder thus yielding a strong CEST signal from urine. By comparing the ST% obtained upon selective irradiation of the two OH resonances belonging to the two isomeric forms of Yb-HPDO3A, it has been possible to measure the extracellular pH for each voxel (0.22 mm(3) ). The obtained pH-maps of tumors show a great heterogeneity. Marked differences are associated to tumor staging. CONCLUSION: The application of Yb-HPDO3A to measure extracellular tumor pH provides a good spatio-temporal resolution and it does not require the prior knowledge of the contrast agent concentration. The herein reported data support the potential clinical translation of Yb-HPDO3A.


Asunto(s)
Líquido Extracelular/química , Compuestos Heterocíclicos con 1 Anillo , Concentración de Iones de Hidrógeno , Imagen por Resonancia Magnética/métodos , Melanoma/química , Melanoma/patología , Iterbio , Animales , Línea Celular Tumoral , Medios de Contraste , Masculino , Ratones , Ratones Endogámicos C57BL , Reproducibilidad de los Resultados , Sensibilidad y Especificidad
3.
J Hazard Mater ; 162(2-3): 1300-8, 2009 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-18692312

RESUMEN

Asbestos-cement roofs, the most widespread sources of airborne, toxic and carcinogenic asbestos fibres, are often colonized by lichens. Since these latter are physical and chemical weathering agents, they have been often considered as significant responsible of disaggregation processes increasing fibre dispersion. Consequently, official guidelines for the management of asbestos often suggest their removal. Weathering and/or covering effects of lichens on asbestos-cement, however, have never been deeply investigated and available procedures to evaluate asbestos-cement aging do not take the biological colonization into account. In this study we show that a 25% lichen cover modifies physical and chemical properties of asbestos-cement sheets containing chrysotile and crocidolite fibres. By innovatively coupling pull up tests and image analysis of linear structures, we show that fibre loss is significantly lower ( approximately 30%) where lichens develop and offer a physical barrier to the fibre detachment. Below the most covering lichens (Acarospora cervina, Candelariella ssp.), chrysotile and crocidolite undergo a partial incongruent dissolution, which in laboratory assays generally determined a reduction of their surface reactivity. Because of their biocovering and bioweathering effects, lichens on asbestos-cement play a role which differs from the current public opinion and the assumptions of some official regulations, acting as effective spontaneous bioattenuation agents.


Asunto(s)
Amianto , Materiales de Construcción , Líquenes , Microscopía Electrónica de Rastreo , Difracción de Rayos X
4.
Eur J Histochem ; 51(4): 283-90, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18162458

RESUMEN

The early radiation of epidermal reactions can lead to healing of the lesion or radiation necrosis. There is no general agreement for either the prevention and/or treatment of radiation skin response, also as little is known about the immediate phases of this phenomenon. We investigated the early effects exerted by Healing and Wound Emulsion (HWE) on human skin response after ionizing radiation. Epidermal morphology, Heat Shock Protein (HSP) 70, and Transforming Growth Factor-beta1 (TGF-beta1) gene expression were investigated in organotypic human skin cultures undergoing a double dose of gamma-rays (2 Gy). HSP70 gene expression tended to be induced in the HWE group 6 hours after cream administration and was significantly up-regulated after 48 hours, when epidermal morphological alterations were evident. TGF-beta1 seems not affected in cream treated samples. HWE may stimulate skin to mount an early defensive response against damage induced by gamma rays.


Asunto(s)
Mama , Emulsiones/farmacología , Epidermis/efectos de los fármacos , Epidermis/efectos de la radiación , Rayos gamma , Radiodermatitis/prevención & control , Adulto , Proliferación Celular/efectos de la radiación , Epidermis/patología , Femenino , Expresión Génica/efectos de los fármacos , Expresión Génica/efectos de la radiación , Proteínas del Choque Térmico HSP72/genética , Humanos , Queratinocitos/efectos de los fármacos , Queratinocitos/patología , Queratinocitos/efectos de la radiación , Necrosis , Técnicas de Cultivo de Órganos , Factor de Crecimiento Transformador beta1/genética , Regulación hacia Arriba
5.
J Control Release ; 230: 57-63, 2016 05 28.
Artículo en Inglés | MEDLINE | ID: mdl-27049069

RESUMEN

The work aimed at developing a novel MRI-based theranostic protocol for improving the anticancer efficacy of a Doxil-like liposomal formulation. The goal was achieved stimulating the intratumor release of the drug from the nanocarrier and favoring its diffusion in the lesion by the sequential application of low-intensity pulsed ultrasound. The protocol was tested on mice bearing a syngeneic breast cancer model. The combination of acoustic waves with different characteristics allowed for: i) the release of the drug and the co-encapsulated MRI agent (Gadoteridol) from the liposomes in the vessels of the tumor region, and ii) the extravasation of the released material, as well as intact liposomes, in the tumor stroma. The MR-T1 contrast enhancement measured in the tumor reported on the delivery and US-triggered release of Doxorubicin. The developed protocol resulted in a marked increase in the intratumor drug concentration that, in turn, led to the complete regression of the lesion. The protocol has a good clinical translatability because all the components of the theranostic agent (Doxorubicin, liposomes, Gadoteridol) are approved for human use.


Asunto(s)
Antibióticos Antineoplásicos/administración & dosificación , Doxorrubicina/análogos & derivados , Neoplasias Mamarias Experimentales/tratamiento farmacológico , Ondas Ultrasónicas , Animales , Antibióticos Antineoplásicos/farmacocinética , Antibióticos Antineoplásicos/uso terapéutico , Línea Celular Tumoral , Medios de Contraste/administración & dosificación , Doxorrubicina/administración & dosificación , Doxorrubicina/farmacocinética , Doxorrubicina/uso terapéutico , Femenino , Gadolinio/administración & dosificación , Compuestos Heterocíclicos/administración & dosificación , Imagen por Resonancia Magnética , Neoplasias Mamarias Experimentales/diagnóstico por imagen , Neoplasias Mamarias Experimentales/metabolismo , Neoplasias Mamarias Experimentales/patología , Ratones Endogámicos BALB C , Compuestos Organometálicos/administración & dosificación , Polietilenglicoles/administración & dosificación , Polietilenglicoles/farmacocinética , Polietilenglicoles/uso terapéutico , Carga Tumoral/efectos de los fármacos
6.
J Control Release ; 202: 21-30, 2015 Mar 28.
Artículo en Inglés | MEDLINE | ID: mdl-25626083

RESUMEN

The main goal of this study was to assess the theranostic performance of a nanomedicine able to generate MRI contrast as a response to the release from liposomes of the antitumor drug Doxorubicin triggered by the local exposure to pulsed low intensity non focused ultrasounds (pLINFU). In vitro experiments showed that Gadoteridol was an excellent imaging agent for probing the release of Doxorubicin following pLINFU stimulation. On this basis, the theranostic system was investigated in vivo on a syngeneic murine model of TS/A breast cancer. MRI offered an excellent guidance for monitoring the pLINFU-stimulated release of the drug. Moreover, it provided: i) an in vivo proof of the effective release of the liposomal content, and ii) a confirmation of the therapeutic benefits of the overall protocol. Ex vivo fluorescence microscopy indicated that the good therapeutic outcome was originated from a better diffusion of the drug in the tumor following the pLINFU stimulus. Very interestingly, the broad diffusion of the drug in the tumor stroma appeared to be mediated by the presence of the liposomes themselves. The results of this study highlighted either the great potential of US-based stimuli to safely trigger the release of a drug from its nanocarrier or the associated significant therapeutic improvement. Finally, MRI demonstrated to be a valuable technique to support chemotherapy and monitoring the outcome. Furthermore, in this specific case, the theranostic agent developed has a high clinical translatability because the MRI agent utilized is already approved for human use.


Asunto(s)
Antibióticos Antineoplásicos/administración & dosificación , Medios de Contraste/administración & dosificación , Doxorrubicina/administración & dosificación , Compuestos Heterocíclicos/administración & dosificación , Neoplasias Mamarias Experimentales/diagnóstico por imagen , Compuestos Organometálicos/administración & dosificación , Animales , Antibióticos Antineoplásicos/química , Antibióticos Antineoplásicos/farmacocinética , Antibióticos Antineoplásicos/uso terapéutico , Línea Celular Tumoral , Medios de Contraste/farmacocinética , Doxorrubicina/química , Doxorrubicina/farmacocinética , Doxorrubicina/uso terapéutico , Femenino , Gadolinio/administración & dosificación , Gadolinio/farmacocinética , Compuestos Heterocíclicos/farmacocinética , Liposomas , Imagen por Resonancia Magnética , Neoplasias Mamarias Experimentales/tratamiento farmacológico , Neoplasias Mamarias Experimentales/metabolismo , Neoplasias Mamarias Experimentales/patología , Ratones Endogámicos BALB C , Compuestos Organometálicos/farmacocinética , Carga Tumoral/efectos de los fármacos , Ultrasonografía
7.
Bone Marrow Transplant ; 19(1): 3-7, 1997 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9012924

RESUMEN

High-dose therapy with bone marrow (BM) or blood stem cell (BSC) support is a high-technology technique usually administered in specialized tertiary centers. The use of BSC has made this technique simpler and accessible also to smaller hospitals. We retrospectively analyzed the data of patients with lymphoma, leukemia and other tumors who received high-dose therapy and BM or BSC transplantation in our district hospital, looking at the type of procedure performed, complications, use of growth factors, and progression-free and overall survival. A total of 40 patients were transplanted over 6 years. No procedure-related deaths and no permanent organ toxicities were seen. The use of BSC brought about a great reduction in the duration of hospital stay, septic complications and transfusion of blood components. For patients with lymphoma (n = 20) the probabilities of progression-free survival and of overall survival at 2 years are 48% (95% C.I. 28-68%) and 68% (95% C.I. 46-84%), respectively. Based on these data, we believe that ABMT and BSC transplantation are feasible and safe in a peripheral hospital when the appropriate human and technical conditions are present. Treatment outcome is then comparable to that of specialized centers.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Neoplasias Hematológicas/terapia , Trasplante de Células Madre Hematopoyéticas , Hospitales Comunitarios , Neoplasias/terapia , Adolescente , Adulto , Terapia Combinada , Femenino , Supervivencia de Injerto , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Suiza , Trasplante Autólogo , Resultado del Tratamiento
8.
Clin Chim Acta ; 225(2): 137-46, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8088003

RESUMEN

We examined the diagnostic validity of an immunoradiometric assay for determination of mass concentration of bone alkaline phosphatase (EC 3.1.3.1) in 134 sera from 35 patients receiving renal transplants. Comparison between bone alkaline phosphatase concentration and total alkaline phosphatase activity yielded a strong correlation (r = +0.860; P < 0.001). Nine (17%) of 54 sera which were characterized by a total alkaline phosphatase activity between 100 units/l and the upper reference limit (178 units/l (males) and 160 units/l (females), respectively) showed an increased bone alkaline phosphatase concentration (> 21.3 micrograms/l (males) and > 15.0 micrograms/l (females), respectively). There was also a correlation between bone alkaline phosphatase values and parathyroid hormone levels both before (r = +0.640 (n = 23), P < 0.001) and after renal transplantation (r = +0.528 (n = 111), P < 0.0001). A follow-up of 15 patients after renal transplantation revealed that the median of bone alkaline phosphatase values increased from 5.5 micrograms/l before transplantation to 14.9 micrograms/l 3 months after transplantation (P < 0.0001). Nevertheless no correlation could be observed between parathyroid hormone concentrations and bone alkaline phosphatase values at any time following renal transplantation in these 15 patients (P > 0.1). Rise of bone alkaline phosphatase concentration following renal transplantation is most probably due to an activating effect of cyclosporin A upon osteoblasts.


Asunto(s)
Fosfatasa Alcalina/análisis , Huesos/citología , Huesos/enzimología , Trasplante de Riñón/fisiología , Osteoblastos/enzimología , Adulto , Anciano , Fosfatasa Alcalina/sangre , Calcio/sangre , Ciclosporina/sangre , Femenino , Humanos , Ensayo Inmunorradiométrico , Masculino , Persona de Mediana Edad , Hormona Paratiroidea/metabolismo
9.
Toxicol In Vitro ; 13(2): 305-12, 1999 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20654488

RESUMEN

The 6th Amendment of the European Directive on Cosmetics induces a potential ban on animal testing for cosmetic ingredients and finished products. In this new context, COLIPA (The European Cosmetic Toiletry and Perfumery Association) has initiated an international multicentric study with the main goal of validating available alternatives to in vitro methods for assessing the eye irritation potential of cosmetic raw materials and formulations. In order to test undiluted and hydrophobic ingredients and formulations, a cytotoxicity test named PREDISAFE was incorporated into our internal battery of in vitro tests for 3 years. This cell culture test based on the neutral red release procedure was prevalidated with several cosmetic formulations and used systematically by comparison with internal benchmarks. In this article, the defined prediction model and the protocol used in the COLIPA eye irritation program are described, and furthermore the PREDISAFE assay results obtained during Phase I of the above mentioned study are presented and discussed in detail. The statistical analysis proves clearly a great interest in the PREDISAFE test for the prediction of eye irritation potential of cosmetic formulations. Its strong compatibility for a wide category of finished products associated with its ease of use offer relevant advantages for a routine use in the ocular irritancy screening in the cosmetics industry. This paper also explains the reasons for false negative and false positive in vitro tests results and describes possible technical modifications to avoid these wrong predictions. At the end, some recommendations for the Phase II of the COLIPA study are considered with the main objective to prove that a multivariable analysis could be useful to find the best battery of in vitro assays for acceptance by the regulators for the replacement of the Draize eye irritation test.

10.
Toxicol In Vitro ; 5(5-6): 555-7, 1991.
Artículo en Inglés | MEDLINE | ID: mdl-20732076

RESUMEN

A multicentre study of alternative methods to the Draize eye irritation test, involving six different laboratories was organized by OPAL (Oeuvre Pour l'Assistance aux Animaux de Laboratoire). Forty chemicals (including solvents, surfactants, acids, bases, and others) were selected for testing by three methods, namely Griffith's test (a low-volume eye irritation test on rabbits), the hen's egg chorioallantoic membrane (HET-CAM) assay for the evaluation of hyperaemia, haemorrhage and coagulation, and neutral red uptake by SIRC cells for the assessment of cytotoxicity. Each method was used in two or three laboratories. Intralaboratory reproducibility was good for each laboratory with values, for error, close to 10%. Interlaboratory agreement was also good, particularly for the cell culture method, a quantitative and objective technique. Griffith's test correlated well with the Draize test (r = 0.846; n = 37), while for the HET-CAM test (r = 0.670; n = 32) and the cell culture method (r = 0.579; n = 32) the correlation was satisfactory. A more complete statistical analysis is currently under way to confirm and extend these preliminary findings.

11.
Toxicol In Vitro ; 11(1-2): 141-79, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-20654303

RESUMEN

The principal goal of this study was to determine whether the results from a set of selected currently available alternative methods as used by cosmetics companies are valid for predicting the eye irritation potential of cosmetics formulations and ingredients and, as a consequence, could be valid replacements for the Draize eye irritation test. For the first time in a validation study, prediction models (PMs) that convert the in vitro data from an assay to a prediction of eye irritation were developed for each alternative method before the study began. The PM is an unequivocal description of the relationship between the in vitro and the in vivo data and allows an objective assessment of the reliability and relevance of the alternative methods. In this study, 10 alternative methods were evaluated using 55 test substances selected as representative of substances commonly used in the cosmetics industry (23 ingredients and 32 formulations). Twenty of the single ingredients were common to the European Commission/British Home Office (EC/HO) eye irritation validation study (Balls et al., 1995b). The test substances were coded and supplied to the participating laboratories. The results were collected centrally and analysed independently, using statistical methods that had been agreed before the testing phase began. Each alternative method was then evaluated for reliability and relevance in assessing eye irritation potential. Using the criteria of both reliability and relevance as defined in the study, the preliminary results indicate that none of the alternative methods evaluated could be confirmed as a valid replacement for the Draize eye irritation test across the full irritation scale. However, three alternative methods-the fluorescein leakage test, the red blood cell assay (classification model) and the tissue equivalent assay-each satisfied one criterion of reliability or relevance. Further investigation of the decoded data from this study to explore more fully the relationship between the in vitro data and the in vivo data is recommended. Such a review may allow the development of new prediction models to be tested in a subsequent validation study.

12.
Chemosphere ; 36(9): 2007-17, 1998 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-9532728

RESUMEN

Ground water samples from an industrialised area near Milan were analysed by gas chromatography-mass spectrometry (GC-MS) to identify the main pollutants and to quantify two classes of chemicals: polychloro-1,3-butadienes (PCBD) and some aromatic amines. The water contained several halogenated aromatic and aliphatic compounds and heavy contamination due to PCBD, probably arising from contaminated land where a disused chemical plant is located. All the samples contained low levels of aromatic amines indicating a diffuse contamination probably arising from different sources.


Asunto(s)
Residuos Industriales , Contaminantes del Agua/análisis , Aminas/análisis , Compuestos de Anilina/análisis , Butadienos/análisis , Cromatografía de Gases y Espectrometría de Masas , Italia
13.
Int J Cosmet Sci ; 22(2): 95-103, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18503465

RESUMEN

The aim of this study was to investigate the effect of retinol on the human adipose conversion process using primary cultured human adipocyte precursor cells. When these cells were seeded in a medium containing retinol (concentrations ranging from 3.5 nM to 3.5 muM), cell proliferation was slightly inhibited by high concentrations of retinol, as demonstrated by cell counting and [(3)H]-thymidine incorporation. Moreover, the differentiation capacities of these cells were markedly and dose-dependently inhibited by retinol, as shown by the reduced expression of the lipogenic enzyme glycerol-3-phosphate dehydrogenase and by microscopic morphological analysis. These results strongly suggest that retinol, by inhibiting the ability of human preadipocytes to convert into mature adipocytes, could be of potential interest in the prevention of human adipose tissue development in general and of cellulitis in particular.

14.
Int J Cosmet Sci ; 23(5): 299-308, 2001 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18498477

RESUMEN

The aim of this study was to investigate the mechanism(s) underlying the antiadipogenic effect of retinol that we recently reported in primary cultured human preadipocytes. Exposure of human preadipocytes to the potent alcohol dehydrogenase inhibitor, 4-methyl-pyrazole, failed to alter the antiadipogenic effect of retinol (3.5 microm), suggesting that the latter effect is due to retinol per se rather than to its oxidation product, retinoic acid (RA). Moreover, retinol, in contrast to what is generally observed with RA, did not alter the expression of the major adipogenic transcriptional factors PPARgamma and C/EBPalpha but, like RA, reduced transcription of an adipospecific gene controlled in part by C/EBP, the ob gene. These results indicate that retinol per se inhibits the adipo-conversion of human preadipocytes and suggest that the mechanisms of this antiadipogenic action implies at least in part inhibition of C/EBP transcriptional activity.

15.
Eur J Drug Metab Pharmacokinet ; 14(2): 145-51, 1989.
Artículo en Inglés | MEDLINE | ID: mdl-2591419

RESUMEN

The pharmacokinetic and pharmacodynamic profiles of metoprolol were studied in adult male rabbits given 3.2 mg/kg i.v. before and during liver failure. The partition of metoprolol between blood cells and plasma averaged 1.14 in both conditions. Plasma protein binding, concentration-independent, was 32% and 17% in normal and pathological status, respectively. With normal liver function the terminal elimination half-life for the drug was 0.54-0.96 h, rising to 1.0-2.1 h in liver failure. Differences of the same order were observed for total plasma drug clearance (average 3.7 vs 1.5 1/h/kg), MRT (0.77 vs 1.92 h), AUC (0.9 vs 2.2 mg h/l) and k10 (3.17 vs 1.80 h-1). Liver impairment did not affect the volume of distribution of the central compartment, the steady-state volume of distribution and the other intercompartmental rate constants. Although metoprolol was eliminated in the urine, the amount excreted was low (1.5% of the administered dose) in both conditions. The pharmacokinetic model was extended by an 'effect compartment', which has no influence on the predetermined mass of drug in the body, to analyse the relationship between heart rate fall and changes in metoprolol plasma concentrations. After drug administration, heart rate fell rapidly about 90 beats in both states. The mean unbound plasma concentration producing 50% of this reduction was double during liver failure compared to normal condition (0.03 vs 0.07 mg/l), but the temporal aspects of drug equilibration with site of action were similar.


Asunto(s)
Hepatopatías/metabolismo , Metoprolol/farmacocinética , Animales , Peso Corporal/efectos de los fármacos , Cromatografía Líquida de Alta Presión , Enzimas/sangre , Frecuencia Cardíaca/efectos de los fármacos , Masculino , Metoprolol/sangre , Metoprolol/farmacología , Modelos Biológicos , Unión Proteica , Conejos
16.
J Cosmet Sci ; 52(1): 1-11, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11382839

RESUMEN

An in vivo method was developed in order to study the photostability of UV filters in a sunscreen. This method assesses sunscreen photostability in the emulsion after direct interaction with the skin. For this purpose UV filters were recovered from volunteers' forearms by using the stripping technique, then extracted from tapes and quantified by high-performance liquid chromatography (HPLC). The photostability of the filters tested was evaluated by comparing the amount of filters recovered from the strippings of UV-irradiated skin (40 minimal erythema dose, or MED) versus non-irradiated skin. Sequential analysis of several successive tapes reflected the distribution profile of the filters in the stratum corneum. Photochemical change was observed for one filter: it was shown to undergo a photochemical modification with the appearance of an additional HPLC peak. Moreover, UV filters tested displayed a high affinity for the stratum corneum but presented different distribution profiles. This in vivo method takes into account the interaction of the sunscreen agents with the stratum corneum. Furthermore, unlike spectrometric methods usually used for photostability assessment, it gives quantitative data for each individual filter of a finished product by using an HPLC technique.


Asunto(s)
Cromatografía Líquida de Alta Presión/métodos , Estabilidad de Medicamentos , Protectores Solares/química , Rayos Ultravioleta , Adulto , Humanos , Piel/efectos de la radiación
17.
Clin Ter ; 140(1): 43-57, 1992 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-1388115

RESUMEN

The efficacy of amlodipine, a long half-life dihydropyridine calcium antagonist, at the dosage of 5-10 mg/day in a single daily administration, has been compared with that of nifedipine R, a short half-life dihydropyridine, at the dosage of 20-40 mg b.i.d. in 29 patients with chronic ischemic heart disease. After a one week placebo period, patients were assigned to the treatment with amlodipine or nifedipine R, according to a randomized sequence and a cross-over, single-blind design, for two control periods of four weeks and without a wash-out interval between these two phases. During the stress test, a significant increase from baseline in test duration and in time to onset of ischemia and of angina have been obtained with both treatments; moreover amlodipine increased significantly the time to onset of ST segment deviation (-1 mm) and the time to maximum ST segment deviation compared with nifedipine R changes. Also with Holter monitoring and in the angina diary there was a significant reduction of anginal episodes. As regards safety profile, amlodipine treatment was associated with a significantly lower incidence of side effects compared with nifedipine R. This is probably due to the particular pharmacokinetics of amlodipine which, besides the long half-life which allows a single daily administration, shows a retarded peak (between the 6th and the 12th hour) with consequent reduction of phenomena connected with fast and excessive peripheral vasodilatation. In conclusion, amlodipine was as effective in reducing the signs of ischemia as nifedipine R, but compliance was better due to the single daily administration and so was tolerability.


Asunto(s)
Bloqueadores de los Canales de Calcio/uso terapéutico , Enfermedad Coronaria/tratamiento farmacológico , Nifedipino/análogos & derivados , Nifedipino/uso terapéutico , Adulto , Anciano , Amlodipino , Bloqueadores de los Canales de Calcio/efectos adversos , Enfermedad Crónica , Enfermedad Coronaria/fisiopatología , Preparaciones de Acción Retardada , Femenino , Hemodinámica/efectos de los fármacos , Hemodinámica/fisiología , Humanos , Masculino , Persona de Mediana Edad , Nifedipino/efectos adversos , Método Simple Ciego
18.
Curr Med Chem ; 17(31): 3684-700, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20846110

RESUMEN

The role of MRI in the armory of diagnostic modalities for the medicine of the forthcoming years largely depends on how chemistry will provide advanced tools to meet the medical needs. This review aims at outlining the most innovative approaches that have been undertaken in the recent history of MRI contrast agents for tackling the challenges of sensitivity and specificity required by the new generation of contrast agents that should allow the visualization of pathological processes occurring on cellular and molecular scale (the so-called Molecular Imaging). Most of the classes of MRI agents clinically approved or currently under investigation in a preclinical phase exploit peculiar magnetic properties of metals. The conventional agents acting as T(1) or T(2)/T(2)* relaxation enhancers are primarily based on the paramagnetic or the superparamagnetic properties of Gd(III)-, Mn(II)- and iron oxides systems. Recently, there has been a renewed interest towards paramagnetic lanthanide complexes with an anisotropic electronic configuration thanks to their ability to induce strong effect on the resonance frequency of the spins dipolarly coupled with them. Such systems, formerly mainly used as shift reagents, have now attracted much attention in the emerging field of Chemical Exchange Saturation Transfer (CEST) MRI agents.


Asunto(s)
Imagen por Resonancia Magnética , Metales , Imagen Molecular , Medios de Contraste/química , Gadolinio/química , Gadolinio/metabolismo , Humanos , Hierro/química , Hierro/metabolismo , Elementos de la Serie de los Lantanoides/química , Elementos de la Serie de los Lantanoides/metabolismo , Magnetismo , Manganeso/química , Manganeso/metabolismo , Sensibilidad y Especificidad
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda